Clinical trial
Comparing Haloperidol to Olanzapine in the Treatment of Suspected Cannabinoid Hyperemesis in the Emergency Department
NCT07246187 is registered in ClinicalTrials.gov with Mercy Bon Secours Saint Vincent Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparing Haloperidol to Olanzapine in the Treatment of Suspected Cannabinoid Hyperemesis in the Emergency Department
- Lead sponsor
- Mercy Bon Secours Saint Vincent Medical Center
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 6, 2025
- Completion date
- October 1, 2026
- Enrollment
- 31 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.